Brandon Folkes
Stock Analyst at H.C. Wainwright
(0.21)
# 4,215
Out of 4,386 analysts
467
Total ratings
34.7%
Success rate
-4.4%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRTX Heron Therapeutics | Maintained: Buy | $2 | $0.4536 | +340.92% | 38 | Jun 8, 2026 | |
| TLPH Talphera | Initiated Coverage: Buy | $4 → $3 | $0.8468 | +254.27% | 19 | Jun 5, 2026 | |
| MNKD MannKind | Reiterated: Buy | $10 | $3.39 | +194.99% | 22 | Jun 1, 2026 | |
| RNTX Rein Therapeutics | Reiterated: Buy | $10 → $8 | $0.9487 | +743.26% | 7 | Jun 1, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.8396 | +1,210.15% | 8 | Jun 1, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $26 | $12.09 | +115.05% | 10 | May 26, 2026 | |
| MIST Milestone Pharmaceuticals | Maintained: Buy | $8 | $1.23 | +550.41% | 14 | May 26, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $12.55 | $1.51 | +731.24% | 12 | May 26, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $2.20 | +218.18% | 13 | May 26, 2026 | |
| VALN Valneva SE | Reiterated: Buy | $18 | $5.34 | +237.39% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $6.53 | +344.10% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.37 | +483.94% | 3 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.05 | +389.00% | 2 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $8.54 | +52.22% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $26.30 | +128.14% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $9.85 | +306.09% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.62 | +181.39% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15.34 | $8.39 | +82.85% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.00 | +116.67% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.48 | +118.98% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.07 | +80.67% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $80.13 | +51.00% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.26 | +80.40% | 40 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.24 | +60.26% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $13.50 | +55.56% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $2.22 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.661 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $8.00 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $2.60 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $0.9907 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $33 | $0.64999998 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $15 | $3.00 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $270.94 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $40 | $1.02 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0011 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $50 | $0.011 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $42.45 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $41.46 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $232.04 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $8 | $0.0001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $22.09 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $14.97 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $31.76 | n/a | 2 | Sep 12, 2016 |
Heron Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $2
Current: $0.4536
Upside: +340.92%
Talphera
Jun 5, 2026
Initiated Coverage: Buy
Price Target: $4 → $3
Current: $0.8468
Upside: +254.27%
MannKind
Jun 1, 2026
Reiterated: Buy
Price Target: $10
Current: $3.39
Upside: +194.99%
Rein Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $0.9487
Upside: +743.26%
Rani Therapeutics Holdings
Jun 1, 2026
Reiterated: Buy
Price Target: $11
Current: $0.8396
Upside: +1,210.15%
Zevra Therapeutics
May 26, 2026
Reiterated: Buy
Price Target: $26
Current: $12.09
Upside: +115.05%
Milestone Pharmaceuticals
May 26, 2026
Maintained: Buy
Price Target: $8
Current: $1.23
Upside: +550.41%
Cardiol Therapeutics Inc.
May 26, 2026
Maintained: Buy
Price Target: $12.55
Current: $1.51
Upside: +731.24%
Connect Biopharma Holdings
May 26, 2026
Reiterated: Buy
Price Target: $7
Current: $2.20
Upside: +218.18%
Valneva SE
May 26, 2026
Reiterated: Buy
Price Target: $18
Current: $5.34
Upside: +237.39%
May 26, 2026
Maintained: Buy
Price Target: $29
Current: $6.53
Upside: +344.10%
May 20, 2026
Reiterated: Buy
Price Target: $8
Current: $1.37
Upside: +483.94%
May 20, 2026
Reiterated: Buy
Price Target: $10
Current: $2.05
Upside: +389.00%
May 15, 2026
Reiterated: Buy
Price Target: $13
Current: $8.54
Upside: +52.22%
May 15, 2026
Reiterated: Buy
Price Target: $60
Current: $26.30
Upside: +128.14%
May 14, 2026
Reiterated: Buy
Price Target: $40
Current: $9.85
Upside: +306.09%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $4.62
Upside: +181.39%
May 14, 2026
Reiterated: Buy
Price Target: $15.34
Current: $8.39
Upside: +82.85%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $6.00
Upside: +116.67%
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $5.48
Upside: +118.98%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $11.07
Upside: +80.67%
May 8, 2026
Reiterated: Buy
Price Target: $121
Current: $80.13
Upside: +51.00%
May 8, 2026
Reiterated: Buy
Price Target: $60
Current: $33.26
Upside: +80.40%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $6.24
Upside: +60.26%
May 8, 2026
Reiterated: Buy
Price Target: $21
Current: $13.50
Upside: +55.56%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $2.22
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $0.661
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $8.00
Upside: n/a
May 3, 2024
Maintained: Buy
Price Target: $3 → $4
Current: $2.60
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $20 → $10
Current: $0.9907
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Maintained: Hold
Price Target: $37 → $33
Current: $0.64999998
Upside: n/a
Feb 9, 2023
Maintained: Buy
Price Target: $22 → $15
Current: $3.00
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $270.94
Upside: n/a
Nov 22, 2022
Maintained: Buy
Price Target: $22 → $40
Current: $1.02
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0011
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $5 → $50
Current: $0.011
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $42.45
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $41.46
Upside: n/a
Oct 6, 2021
Maintained: Buy
Price Target: $210
Current: $232.04
Upside: n/a
Aug 9, 2021
Maintained: Buy
Price Target: $6 → $8
Current: $0.0001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $22.09
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $14.97
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $31.76
Upside: n/a